New York Society for Gastrointestinal Endoscopy (NYSGE) 41st Annual New York Course

New York Society for Gastrointestinal Endoscopy (NYSGE) 41st Annual New York Course is organized by New York Society for Gastrointestinal Endoscopy (NYSGE) and will be held during Dec 14 - 15, 2017 at New York Marriott Marquis, New York, United States of America.

The target audience for this medical event is Practicing gastroenterologists, gastrointestinal endoscopists, surgeons, GI fellows, and GI nurses and associates. This CME conference has been approved for a maximum of 16.0 AMA PRA Category 1 Credits.

Course Description:
Under the direction of expert faculty, this course is designed to improve endoscopic practice through live case presentations, video and hands-on demonstrations, didactic lectures including audience interaction and questions, and hands-on training using animal tissue models.

The course goals are to help participants improve their ability to accurately diagnose and effectively treat the spectrum of gastrointestinal diseases and disorders, enhance quality in all practice settings, embrace advances in healthcare delivery, payment systems, and healthcare information sharing; apply state-of-the-art technology in a cost-effective way, understand trends in interventional endoscopic and surgical procedures, and to foster an evidence-based approach to endoscopic decision-making for commonly encountered and controversial problems in gastroenterology.

Conference Objectives are :
• Develop practice patterns and standard procedures that incorporate objective measurements of quality metrics in the daily clinical practice of endoscopy, and use the results to make continuous improvement in patient care across a range of clinical gastroenterology procedures
• Examine and discuss novel endoscopic therapies in comparison to traditional medical and interventional treatments
• Demonstrate tools and skills necessary to accurately identify and effectively treat complications of gastrointestinal endoscopy
• Identify appropriate tests and methods to assess mucosal damage and disease status in patients with inflammatory bowel disease, and then apply methods to evaluate healing and successful treatment
Evaluate the effectiveness and safety of new treatments for hepatitis

Topics
Topics include GERD, ablation and resection therapies for Barrett’s esophagus, eosinophilic esophagitis, and other esophageal disorders; motility testing; upper, lower and obscure GI bleeding; advanced imaging and new technologies; small bowel and colon capsule endoscopy; small bowel disorders; inflammatory bowel disease; irritable bowel syndrome, celiac disease, management of colitis; biosimilars; fecal transplantation for C. difficile; colorectal cancer screening, and disorders of the colon and rectum; polyp detection and polypectomy including duodenal polyps; ESD and POEM, GI complications, endoscopic ultrasound and therapeutic EUS; ERCP for biliary and pancreatic disease including cysts and drainage of fluid collections; hereditary pancreatic and colon cancer syndromes; managing neuroendocrine tumors; viral hepatitis and endoscopy in liver disease; infection control in the endoscopy suite; endoscopic therapies for obesity, and many others.